Conference
Tamoxifen versus tamoxifen plus octreotide LAR as adjuvant therapy for early-stage breast cancer in postmenopausal women: Update of NCIC CTG MA14 trial.
Authors
Pollak MN; Chapman JW; Pritchard KI; Krook JE; Dhaliwal HS; Vandenberg TA; Whelan TJ; O'Reilly SE; Wilson CF; Shepherd LE
Volume
28
Pagination
pp. 542-542
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2010
DOI
10.1200/jco.2010.28.15_suppl.542
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X